Helminthic Infestations Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: H09475433514EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Helminthic Infestations Therapeutics in Global, including the following market information:

Global Helminthic Infestations Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Helminthic Infestations Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Benzimidazole Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Helminthic Infestations Therapeutics include Neural Analytics, Inc., M3 Biotechnology, Inc., Cerevance, Mitochon Pharmaceuticals, Inc., Peptilogics, Farmoquimica S/A, biOasis Technologies, Inc., HCA Healthcare, Inc. and Alzeca Biosciences, Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Helminthic Infestations Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Helminthic Infestations Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Helminthic Infestations Therapeutics Market Segment Percentages, by Type, 2021 (%)
  • Benzimidazole
  • Pyrantel
  • Piperazine Citrate
  • Others
Global Helminthic Infestations Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Helminthic Infestations Therapeutics Market Segment Percentages, by Application, 2021 (%)
  • Enterobius vermicularis
  • Taenia saginata
  • Ascaris lumbricoides
  • Trichuris trichiura
  • Others
Global Helminthic Infestations Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Helminthic Infestations Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Helminthic Infestations Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Helminthic Infestations Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Neural Analytics, Inc.
  • M3 Biotechnology, Inc.
  • Cerevance
  • Mitochon Pharmaceuticals, Inc.
  • Peptilogics
  • Farmoquimica S/A
  • biOasis Technologies, Inc.
  • HCA Healthcare, Inc.
  • Alzeca Biosciences, Inc.
  • Johnson & Johnson
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Helminthic Infestations Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Helminthic Infestations Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HELMINTHIC INFESTATIONS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Helminthic Infestations Therapeutics Market Size: 2021 VS 2028
2.2 Global Helminthic Infestations Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Helminthic Infestations Therapeutics Players in Global Market
3.2 Top Global Helminthic Infestations Therapeutics Companies Ranked by Revenue
3.3 Global Helminthic Infestations Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Helminthic Infestations Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Helminthic Infestations Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Helminthic Infestations Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Helminthic Infestations Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Helminthic Infestations Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Helminthic Infestations Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Benzimidazole
  4.1.3 Pyrantel
  4.1.4 Piperazine Citrate
  4.1.5 Others
4.2 By Type - Global Helminthic Infestations Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Helminthic Infestations Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Helminthic Infestations Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Helminthic Infestations Therapeutics Market Size, 2021 & 2028
  5.1.2 Enterobius vermicularis
  5.1.3 Taenia saginata
  5.1.4 Ascaris lumbricoides
  5.1.5 Trichuris trichiura
  5.1.6 Others
5.2 By Application - Global Helminthic Infestations Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Helminthic Infestations Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Helminthic Infestations Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Helminthic Infestations Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Helminthic Infestations Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Helminthic Infestations Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Helminthic Infestations Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Helminthic Infestations Therapeutics Revenue, 2017-2028
  6.3.2 US Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.3.3 Canada Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Helminthic Infestations Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Helminthic Infestations Therapeutics Revenue, 2017-2028
  6.4.2 Germany Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.4.3 France Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.4.5 Italy Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.4.6 Russia Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Helminthic Infestations Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Helminthic Infestations Therapeutics Revenue, 2017-2028
  6.5.2 China Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.5.3 Japan Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.5.6 India Helminthic Infestations Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Helminthic Infestations Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Helminthic Infestations Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Helminthic Infestations Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.7.3 Israel Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Helminthic Infestations Therapeutics Market Size, 2017-2028
  6.7.5 UAE Helminthic Infestations Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Neural Analytics, Inc.
  7.1.1 Neural Analytics, Inc. Corporate Summary
  7.1.2 Neural Analytics, Inc. Business Overview
  7.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Major Product Offerings
  7.1.4 Neural Analytics, Inc. Helminthic Infestations Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Neural Analytics, Inc. Key News
7.2 M3 Biotechnology, Inc.
  7.2.1 M3 Biotechnology, Inc. Corporate Summary
  7.2.2 M3 Biotechnology, Inc. Business Overview
  7.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Major Product Offerings
  7.2.4 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 M3 Biotechnology, Inc. Key News
7.3 Cerevance
  7.3.1 Cerevance Corporate Summary
  7.3.2 Cerevance Business Overview
  7.3.3 Cerevance Helminthic Infestations Therapeutics Major Product Offerings
  7.3.4 Cerevance Helminthic Infestations Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Cerevance Key News
7.4 Mitochon Pharmaceuticals, Inc.
  7.4.1 Mitochon Pharmaceuticals, Inc. Corporate Summary
  7.4.2 Mitochon Pharmaceuticals, Inc. Business Overview
  7.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Major Product Offerings
  7.4.4 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Mitochon Pharmaceuticals, Inc. Key News
7.5 Peptilogics
  7.5.1 Peptilogics Corporate Summary
  7.5.2 Peptilogics Business Overview
  7.5.3 Peptilogics Helminthic Infestations Therapeutics Major Product Offerings
  7.5.4 Peptilogics Helminthic Infestations Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Peptilogics Key News
7.6 Farmoquimica S/A
  7.6.1 Farmoquimica S/A Corporate Summary
  7.6.2 Farmoquimica S/A Business Overview
  7.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Major Product Offerings
  7.6.4 Farmoquimica S/A Helminthic Infestations Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Farmoquimica S/A Key News
7.7 biOasis Technologies, Inc.
  7.7.1 biOasis Technologies, Inc. Corporate Summary
  7.7.2 biOasis Technologies, Inc. Business Overview
  7.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Major Product Offerings
  7.7.4 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 biOasis Technologies, Inc. Key News
7.8 HCA Healthcare, Inc.
  7.8.1 HCA Healthcare, Inc. Corporate Summary
  7.8.2 HCA Healthcare, Inc. Business Overview
  7.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Major Product Offerings
  7.8.4 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 HCA Healthcare, Inc. Key News
7.9 Alzeca Biosciences, Inc.
  7.9.1 Alzeca Biosciences, Inc. Corporate Summary
  7.9.2 Alzeca Biosciences, Inc. Business Overview
  7.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Major Product Offerings
  7.9.4 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Alzeca Biosciences, Inc. Key News
7.10 Johnson & Johnson
  7.10.1 Johnson & Johnson Corporate Summary
  7.10.2 Johnson & Johnson Business Overview
  7.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Major Product Offerings
  7.10.4 Johnson & Johnson Helminthic Infestations Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Johnson & Johnson Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Helminthic Infestations Therapeutics Market Opportunities & Trends in Global Market
Table 2. Helminthic Infestations Therapeutics Market Drivers in Global Market
Table 3. Helminthic Infestations Therapeutics Market Restraints in Global Market
Table 4. Key Players of Helminthic Infestations Therapeutics in Global Market
Table 5. Top Helminthic Infestations Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Helminthic Infestations Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Helminthic Infestations Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Helminthic Infestations Therapeutics Product Type
Table 9. List of Global Tier 1 Helminthic Infestations Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Helminthic Infestations Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Helminthic Infestations Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Helminthic Infestations Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Helminthic Infestations Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Helminthic Infestations Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Helminthic Infestations Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Helminthic Infestations Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Neural Analytics, Inc. Corporate Summary
Table 31. Neural Analytics, Inc. Helminthic Infestations Therapeutics Product Offerings
Table 32. Neural Analytics, Inc. Helminthic Infestations Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. M3 Biotechnology, Inc. Corporate Summary
Table 34. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Product Offerings
Table 35. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Cerevance Corporate Summary
Table 37. Cerevance Helminthic Infestations Therapeutics Product Offerings
Table 38. Cerevance Helminthic Infestations Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Mitochon Pharmaceuticals, Inc. Corporate Summary
Table 40. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Product Offerings
Table 41. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Peptilogics Corporate Summary
Table 43. Peptilogics Helminthic Infestations Therapeutics Product Offerings
Table 44. Peptilogics Helminthic Infestations Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Farmoquimica S/A Corporate Summary
Table 46. Farmoquimica S/A Helminthic Infestations Therapeutics Product Offerings
Table 47. Farmoquimica S/A Helminthic Infestations Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. biOasis Technologies, Inc. Corporate Summary
Table 49. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Product Offerings
Table 50. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. HCA Healthcare, Inc. Corporate Summary
Table 52. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Product Offerings
Table 53. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Alzeca Biosciences, Inc. Corporate Summary
Table 55. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Product Offerings
Table 56. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Helminthic Infestations Therapeutics Product Offerings
Table 59. Johnson & Johnson Helminthic Infestations Therapeutics Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Helminthic Infestations Therapeutics Segment by Type in 2021
Figure 2. Helminthic Infestations Therapeutics Segment by Application in 2021
Figure 3. Global Helminthic Infestations Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Helminthic Infestations Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Helminthic Infestations Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Helminthic Infestations Therapeutics Revenue in 2021
Figure 8. By Type - Global Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Helminthic Infestations Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Helminthic Infestations Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Neural Analytics, Inc. Helminthic Infestations Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cerevance Helminthic Infestations Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Peptilogics Helminthic Infestations Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Farmoquimica S/A Helminthic Infestations Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson Helminthic Infestations Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications